BR9205810A - Pyridazinone Acetic Acids - Google Patents

Pyridazinone Acetic Acids

Info

Publication number
BR9205810A
BR9205810A BR9205810A BR9205810A BR9205810A BR 9205810 A BR9205810 A BR 9205810A BR 9205810 A BR9205810 A BR 9205810A BR 9205810 A BR9205810 A BR 9205810A BR 9205810 A BR9205810 A BR 9205810A
Authority
BR
Brazil
Prior art keywords
acetic acids
pyridazinone acetic
pyridazinone
acids
acetic
Prior art date
Application number
BR9205810A
Other languages
Portuguese (pt)
Inventor
Banavara L Mylari
William J Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9205810A publication Critical patent/BR9205810A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
BR9205810A 1991-03-28 1992-03-09 Pyridazinone Acetic Acids BR9205810A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67691991A 1991-03-28 1991-03-28
PCT/US1992/001603 WO1992017446A2 (en) 1991-03-28 1992-03-09 Pyridazinone acetic acids aldose reductase inhibitors

Publications (1)

Publication Number Publication Date
BR9205810A true BR9205810A (en) 1994-06-28

Family

ID=24716565

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9205810A BR9205810A (en) 1991-03-28 1992-03-09 Pyridazinone Acetic Acids

Country Status (19)

Country Link
EP (1) EP0582643A1 (en)
JP (1) JPH06500793A (en)
CN (1) CN1065269A (en)
AU (1) AU658887B2 (en)
BR (1) BR9205810A (en)
CA (1) CA2107104A1 (en)
CZ (1) CZ387092A3 (en)
DE (1) DE9290035U1 (en)
FI (1) FI934222A (en)
HU (1) HUT67836A (en)
IE (1) IE920979A1 (en)
IL (1) IL101325A0 (en)
MX (1) MX9201414A (en)
NZ (1) NZ242152A (en)
PT (1) PT100301A (en)
TW (1) TW207998B (en)
WO (1) WO1992017446A2 (en)
YU (1) YU30392A (en)
ZA (1) ZA922238B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1236720B1 (en) * 2001-02-28 2005-06-15 Pfizer Products Inc. Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors
SE0100873D0 (en) * 2001-03-13 2001-03-13 Astrazeneca Ab Method of treatment
ATE348100T1 (en) 2001-03-30 2007-01-15 Pfizer Prod Inc INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF PYRIDAZINONE ALDOSE REDUCTASE INHIBITORS.
AU761191B2 (en) * 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
US7572910B2 (en) 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
CN111617072B (en) * 2019-02-27 2023-06-20 苏州凯祥生物科技有限公司 Hyperuricemia medicine composition and medicine for treating hyperuricemia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0676391B2 (en) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド Process for producing oxophthalazinyl acetic acid having heterocyclic side chain such as benzothiazole
FR2647676A1 (en) * 1989-06-05 1990-12-07 Union Pharma Scient Appl New pyridazinone derivatives, processes for preparing them and medicaments containing them which are useful, in particular, as aldose reductase inhibitors

Also Published As

Publication number Publication date
CN1065269A (en) 1992-10-14
JPH06500793A (en) 1994-01-27
CA2107104A1 (en) 1992-09-29
NZ242152A (en) 1994-07-26
FI934222A0 (en) 1993-09-27
IE920979A1 (en) 1992-10-07
HUT67836A (en) 1995-05-29
CZ387092A3 (en) 1994-02-16
EP0582643A1 (en) 1994-02-16
FI934222A (en) 1993-09-27
WO1992017446A2 (en) 1992-10-15
AU1779692A (en) 1992-11-02
AU658887B2 (en) 1995-05-04
DE9290035U1 (en) 1993-11-18
YU30392A (en) 1994-11-15
MX9201414A (en) 1992-10-01
HU9302728D0 (en) 1993-12-28
TW207998B (en) 1993-06-21
ZA922238B (en) 1993-09-27
WO1992017446A3 (en) 1992-11-26
IL101325A0 (en) 1992-11-15
PT100301A (en) 1993-06-30

Similar Documents

Publication Publication Date Title
BR9206443A (en) Imidazoyl-alkenoic acids.
AP9200447A0 (en) Acetic acid derivatives
DE69124516D1 (en) catheter
NO922226D0 (en) 7-ISOINDOLINYL-QUINOLON AND NAVYTHYRIDON CARBOXYLIC ACID DERIVATIVES
NO921840D0 (en) SUBSTITUTED CARBOXYLIC ACID DERIVATIVES
DE69133019D1 (en) IMIDAZOLYL-alkene carboxylic acids
DE69207785T2 (en) Heating head
DK152892D0 (en) pyridazinone
DE4293023T1 (en) Quick connection recording
NO920420D0 (en) 3-quinuclidine derivative
DE9290035U1 (en) Pyridazinone acetic acids
DE59205221D1 (en) 1-alkoxyhexatriene-2-carboxylic acid ester
DE69305714D1 (en) Removable carboxylic acids
FI933588A0 (en) (CARBOXYL) ALKYLOXYALKYLDERIVAT AV CYKLODEXTRINER
MX9101098A (en) PIRIDILTIO OR PIRIDILOXI-ALCANOIC ACIDS
NO921530L (en) PHARMASOEYTIC CONNECTION
NO921529D0 (en) PHARMASOEYTIC CONNECTION
NO933446D0 (en) Pyridazinone acetic acids
FI944482A0 (en) Acetic acid recovery
ITMI910513A1 (en) NEW INDAZOLIC ACIDS
IT9019539A1 (en) INDAZOLIC ACIDS
NO920022D0 (en) SATURDED HYDROXYLKYLKINOLIC ACIDS
KR930009125U (en) Connection
KR920015591U (en) VTR
KR930004482U (en) Clap

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal